Image Credits - linkedin
Advertisement
CenExel iResearch and CenExel ACMR, two leading Centers of Excellence based in Atlanta, Georgia, have announced the launch of a dedicated PET Scan Unit at the CenExel ACMR campus. This state-of-the-art facility is designed to meet the growing demand for high-quality imaging services in clinical research, surpassing the capabilities of existing local imaging centres.
The new PET Scan Unit is equipped with advanced technology and will be staffed by a team of highly trained professionals specializing in clinical trial methodologies. This development represents a significant advancement in medical imaging research and aims to enhance the quality and efficiency of clinical trials conducted at CenExel’s facilities.
Ryan Brooks, Chief Executive Officer of CenExel, emphasized the importance of the new unit, saying, “The launch of our dedicated PET Scan Unit at the CenExel ACMR campus represents a major step forward in our dedication to advancing medical research. With our state-of-the-art technology and skilled team, we are confident that this unit will drive groundbreaking discoveries and enhance patient care.”
The establishment of the PET Scan Unit is a testament to CenExel’s dedication to innovation and research excellence. It highlights the company’s ongoing efforts to support the life sciences industry by providing top-notch facilities and services that drive scientific advancement.
CenExel is a premier nationwide network of clinical research sites, committed to supporting the life sciences industry in developing transformative therapies. CenExel employs more than 1,200 staff across 18 major U.S. cities. metropolitan areas, with a steadfast commitment to quality, patient experience, and client success, all aimed at achieving successful clinical development outcomes. The company’s commitment to quality and client success ensures effective clinical development outcomes, helping pharmaceutical and biotech companies gain deeper insights into diseases and accelerate the delivery of innovative treatments.